跳至主要内容
临床试验/IRCT2017082234497N2
IRCT2017082234497N2已完成3 期

Clinical trial of the effect of probiotic supplementation compared with the placebo on disease severity, mental health, insulin resistance, inflammatory factors and biomarkers of oxidative stress in patients with multiple sclerosis

Vice chancellor for research, Kashan University of Medical Sciences0 个研究点目标入组 48 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
48

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20 years 至 60 years(—)
性别
All

入选标准

  • Patients with multiple sclerosis identified according to McDonald criteria
  • Course of disease relapsing–remitting MS (RRMS)
  • EDSS =4.5

排除标准

  • Primary progressive MS (PPMS)
  • Secondary progressive MS (SPMS)
  • Relapse and glucocorticoid therapy during the past one month
  • Women who were lactating within the prior six month
  • Nephrolithiasis
  • Consumption of of probiotic or synbiotic during the past three month

研究者

发起方
Vice chancellor for research, Kashan University of Medical Sciences

相似试验